Literature DB >> 1278646

Effect of secretin on gastric function in normal subjects and in patients with duodenal ulcer.

M D Dalton, A M Eisenstein, J H Walsh, J S Fordtran.   

Abstract

The effect of constant intravenous infusion of secretin in doses of 0.25, 0.50, 1.50, and 3.0 mug per kg per hr on meal-stimulated acid secretion was measured in vitro titration to pH 5.0. The pattern and degree of secretin inhibition of food-stimulated acid secretion depended on when the secretin infusion was begun, the effect being more pronounced when the secretin was begun 1 hr before the test meal than when the meal and secretin infusions were begun simultaneously. Inhibition of acid secretion in normals was approximately the same as in 2 patients with pancreatic exocrine insufficiency who could secrete only small amounts of pancreatic bicarbonate in response to secretin. Secretin in dose of 0.25 and 0.5 mug per kg per hr inhibited acid secretion only slightly, whereas 3.0 mug per kg per hr completely stopped acid secretion. Inhibition of acid secretion by secretin was similar in controls and in patients with duodenal ulcer. Secretin also reduced the rise in serum gastrin concentration after the meal, and delayed gastric emptying; both responses were approximately the same in normals and in duodenal ulcer patients. Secretin inhibited basal gastric acid secretion but had no consistent effect on basal serum gastrin concentration.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1278646

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  9 in total

1.  Acid and endocrine responses to meals varying in pH in normal and duodenal ulcer subjects.

Authors:  J C Thompson; J S Swierczek
Journal:  Ann Surg       Date:  1977-10       Impact factor: 12.969

2.  Secretin provocation in normal and duodenal ulcer subjects. Is the gastrin rise in Zollinger-Ellison syndrome paradoxic or exaggeration?

Authors:  C E Brady; S J Utts; J Dev
Journal:  Dig Dis Sci       Date:  1987-03       Impact factor: 3.199

3.  Effects of parenteral secretin--cholecystokinin and of duodenal acid perfusion on gastric secretion in duodenal ulcer patients.

Authors:  J Butt; T Yoshida; B Fleshler
Journal:  Am J Dig Dis       Date:  1977-04

4.  Altered solid and liquid gastric emptying in patients with duodenal ulcer disease.

Authors:  G J Maddern; M Horowitz; D J Hetzel; G G Jamieson
Journal:  Gut       Date:  1985-07       Impact factor: 23.059

5.  Role of endogenous secretin in acid-induced inhibition of human gastric function.

Authors:  J H Kleibeuker; V E Eysselein; V E Maxwell; J H Walsh
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

6.  Effect of secretin on stress-induced gastric bleeding in rats.

Authors:  M Murakami; H Fujisaki; K Oketani; T Wakabayashi
Journal:  Dig Dis Sci       Date:  1985-04       Impact factor: 3.199

7.  Effect of human gastrin infusion on gastric potential difference in man.

Authors:  A Tarnawski; J E McGuigan; K J Ivey
Journal:  Dig Dis Sci       Date:  1980-11       Impact factor: 3.199

8.  Effect of somatostatin, secretin, and glucagon on secretagogue stimulated aminopyrine uptake in isolated canine parietal cells.

Authors:  E Perez-Reyes; N A Payne; J G Gerber
Journal:  Agents Actions       Date:  1983-06

9.  Endocrinology of duodenal ulcer.

Authors:  W Creutzfeldt; R Arnold
Journal:  World J Surg       Date:  1979-09-20       Impact factor: 3.352

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.